From Prompt to Pitch: How Generative AI Shapes Job Interview Preparation in Female Candidates
Journal of Business Diversity · 2026
DOI: 10.33423/54cn3021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Business Diversity, 2026. Verfasst von Dina Domrös-Zoungrana und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Despite recent progress, women remain underrepresented in senior leadership, underscoring the need for effective support strategies. This exploratory study examined the potential of generative artificial intelligence (AI), particularly Large Language Models (LLMs), to support interview preparation among female professionals. Fourteen women prepared for simulated leadership interviews with or without AI support. Preparation time was captured via post-interview questionnaires. Interview performance, assessed by blinded evaluators, and self-assessments were measured using Likert scales. AI-supported participants showed a numerical trend toward greater time efficiency without reduced interview performance. Subtle shifts in self-perception were observed. Larger studies are needed to validate these exploratory findings.
Zitieren
APA
Domrös-Zoungrana, D., Reis, F., Baum, C., Kube, F., Nguyen, T. T., Sadowsky, N. N., & Lenz, C. (2026). From Prompt to Pitch: How Generative AI Shapes Job Interview Preparation in Female Candidates. Journal of Business Diversity. https://doi.org/10.33423/54cn3021
Vancouver
Domrös-Zoungrana D, Reis F, Baum C, Kube F, Nguyen TT, Sadowsky NN, et al. From Prompt to Pitch: How Generative AI Shapes Job Interview Preparation in Female Candidates. Journal of Business Diversity. 2026. doi:10.33423/54cn3021
BibTeX
@article{DomrsZoungrana2026,
author = {Domrös-Zoungrana, Dina and Reis, Florian and Baum, Catharina and Kube, Frederic and Nguyen, Tang Thim and Sadowsky, Nadja Natascha and Lenz, Christian},
title = {From Prompt to Pitch: How Generative AI Shapes Job Interview Preparation in Female Candidates},
journal = {Journal of Business Diversity},
year = {2026},
doi = {10.33423/54cn3021}
}
EUVIMED